| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4017079a4f3668b61b8c7562e9d21234 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2004-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_445b16c9b3885a74b9bd2657adde2408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e149fad9d1fec368ec51d088f5c4772e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_585e9a0d93624dfa16b13ed48e482ff6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_363c06bd3be2ab4fab2a700bd7b55e6b |
| publicationDate |
2006-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1667681-A1 |
| titleOfInvention |
A novel transmucosal delivery system |
| abstract |
The novel trans mucosal dosage form of this invention relates. to -benzimidazole class of proton pump inhibitors and their precursors, derivatives or salts for the delivery of the drugs in the oral cavity. The novel transmucosal dosage forms do not require enteric coating, or any other coating or excess sodium ions commonly employed for this class of drugs. Commonly used site of absoq.)tion for this invention relates to sublingual, gingival or other oral mucosa. |
| priorityDate |
2003-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |